Please check your internet connection and try again.
# Hyoscine Butylbromide (Buscopan)
## Overview
Hyoscine butylbromide is an anticholinergic medication that works by blocking acetylcholine at muscarinic receptors, resulting in smooth muscle relaxation, particularly in the gastrointestinal and genitourinary tracts.
## Primary Indications
* Symptomatic relief of abdominal cramps and spasms.
* Management of irritable bowel syndrome (IBS) symptoms.
* Pre-procedural bowel preparation (adjunct).
## Adult Dosing
* **Oral:** 20 mg up to 4 times daily. Maximum daily dose not explicitly defined but typically limited by patient tolerance and symptom control.
* **Intramuscular/Intravenous:** 20 mg as a single dose. May be repeated every 4-8 hours if needed. Maximum daily dose typically 100 mg.
## Pediatric Dosing
* **Oral:**
* Children 6-12 years: 10 mg up to 3 times daily.
* Children under 6 years: Not generally recommended due to lack of established dosing and potential for anticholinergic effects. Consult product labeling or specialist.
* **Intramuscular/Intravenous:** Dosing in children is not well-established and requires careful consideration of risk-benefit. Consult specialized pediatric protocols or refer to expert resources if necessary.
## Dose Adjustments
No specific dose adjustments for hepatic or renal impairment are typically required due to minimal systemic absorption and metabolism. However, caution is advised in elderly patients due to increased sensitivity to anticholinergic effects.
## Contraindications
* Hypersensitivity to hyoscine butylbromide or any component of the formulation.
* Myasthenia gravis.
* Glaucoma (narrow-angle).
* Tachyarrhythmias.
* Megaloblastic anemia (due to potential interference with vitamin B12 absorption, especially with prolonged parenteral use).
* Gastrointestinal obstruction or ileus.
* Urinary retention.
* Atropine or belladonna alkaloid sensitivity.
## Adverse Effects
Common: Dry mouth, blurred vision, constipation, urinary retention, mild tachycardia, dizziness, drowsiness.
Less Common/Serious: Allergic reactions (including anaphylaxis), ileus, urinary retention, glaucoma exacerbation.
## Key Drug Interactions
* **Other anticholinergics (e.g., atropine, tricyclic antidepressants, some antihistamines):** Additive anticholinergic effects, increasing the risk of adverse events.
* **Dopamine antagonists (e.g., metoclopramide):** May reduce the efficacy of both agents.
* **Beta-blockers:** Potential for increased heart rate due to decreased vagal tone.
## Monitoring
* Symptom relief and adverse effects.
* For parenteral use: Vital signs, signs of urinary retention.
## Clinical Pearls
* Hyoscine butylbromide has a quaternary ammonium structure, which limits its ability to cross the blood-brain barrier, resulting in fewer central nervous system side effects compared to atropine.
* Onset of action is rapid with parenteral administration (within minutes).
* Ensure adequate hydration to mitigate constipation risk, especially with oral use.
* Use with caution in very young children and the elderly.
**Disclaimer:** This information is intended for clinical decision support and does not replace professional judgment. Always consult the most current prescribing information approved by regulatory authorities and institutional protocols before administering any medication.
